No Picture
News

Innovent Announces the New Drug Application of IBI311 (IGF-1R antibody) has been Accepted by the NMPA of China for Thyroid Eye Disease

SAN FRANCISCO and SUZHOU, China, May 20, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune,… Click […]

No Picture
News

STAT+: AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing. To read of AI’s feats in press releases is to learn […]

News

Gilead Touts Phase III Results for Liver Disease Drug Ahead of PDUFA Date

Published: May 20, 2024 By Tyler Patchen Pictured: Gilead corporate headquarters in Silicon Valley iStock/Sundry Photography Gilead Sciences announced Saturday that Seladelpar, part of the $4.3 billion purchase of CymaBay in February 2024, posted positive interim late-stage results in patients […]

News

FDNA and Genome Medical Improve Access to Critical Diagnostic Services for Children in Medically Underserved Areas

Partnership combines AI technology and telehealth genetic counseling services to improve access and quality of care through early interventions for children with developmental conditions SOUTH SAN FRANCISCO, Calif. and ATLANTA, May 20, 2024 /PRNewswire/ — […]

No Picture
News

Study Demonstrates MyPhenome™ Hungry Gut Test Identifies Responders to Semaglutide

New independent study’s findings presented during Presidential Plenary session at Digestive Disease Week 2024. MENLO PARK, Calif., May 20, 2024 /PRNewswire/ — Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to […]

No Picture
News

Accelerating the Scientific AI Revolution: TetraScience and Databricks Join Forces To Transform Scientific Research, Development, Manufacturing, and Quality Control in Life Sciences

BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–TetraScience and Databricks today announced a strategic partnership dedicated to helping life sciences organizations harness Scientific AI to bring more effective and safer therapies to market faster and less expensively. The […]

No Picture
News

Rila Therapeutics Announces Dosing of First Cohort in Phase 1 Clinical Trial of RLA-23174, a First-In-Class HIPK2 Allosteric Inhibitor, For Treatment of Chronic Kidney Disease and Fibrosis

SOUTH SAN FRANCISCO, Calif., May 20, 2024 /PRNewswire/ — Rila Therapeutics, Inc., A biotechnology company focused on addressing the burden of chronic fibrotic diseases, today announced that the first cohort of subjects was dosed in […]